For example, in studies on the murine melanoma line B16-F10, only ∼0.1% of cells expressed the CD133 marker, and immunomagnetic isolation of this subpopulation revealed superior in vitro proliferative and clonogenic potential compared to CD133-negative cells or the mixed population. The gene discussed is PROM1; the disease is melanoma.